Market sentiment signals for Kymera Therapeutics (KYMR): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
35 analysts
Options Flow (P/C)
0.03
More calls — Bullish
Avg Consensus PT
$115
+9.5%
Highest Price Target
$170
+61.9%
Lowest Price Target
$44
-58.1%
Short Interest
15.3%
Declining — Bullish
Insider Activity (30d)
Neutral
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | Raymond James | Thomas Deal— | +33.3% | $140 | Initiate | Outperform |
| Oct 5, 2026 | Citigroup | Geoff Meacham— | +42.9% | $135 → $150 | Maintained | Buy |
